Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

First Evaluation of a Craniofacial Nerve Stimulation System in Chronic Migraine

NCT: NCT05858801 · ACTIVE_NOT_RECRUITING

NCT IDNCT05858801
StatusACTIVE_NOT_RECRUITING
Start Date2023-05-09
Completion2027-12-31
SponsorSalvia BioElectronics (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to demonstrate the safe use of the PRIMUS system in subjects with chronic migraine. This is a single-center, open label, prospective, early feasibility study to collect initial clinical data on the PRIMUS system for the treatment of chronic migraine.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑